Anti-coagulant therapy after valvular heart surgery

  • Ali Syahputra Departemen Kardiologi dan Kedokteran Vaskular FKUI dan Pusat Jantung Nasional Harapan Kita, Jakarta
  • Yoga Yuniadi Departemen Kardiologi dan Kedokteran Vaskular FKUI dan Pusat Jantung Nasional Harapan Kita, Jakarta


The development of valvular surgery has enabled many patients to lead active and useful lives. Prosthetic heart valves improve quality of life and survival of patients with severe valvular heart disease, but the need for antithrombotic therapy to prevent thrombotic complications in valve recipients poses challenges for clinicians and patients. Advances in antithrombotic therapy and valve technologies are likely to improve the management of patients with heart valves surgery.


Download data is not yet available.


Mc Gee Edwin C Jr, Vlahakes Gus J, De La Torre Ralph. Valve Replacement Therapy: History, Options, and Valve Types. in Sabiston & Spencer – Surgery of The Chest Volume II, Chapter 72, 7th Ed, Elsivier Science 2005: 1273-83.

Sun JCJ, Davidson MJ, Lanny A, Eikelboom JW. Antithrom-botic management of patients with prosthetic hearts valve: cur-rent evidence and future trends. Lancet. 2009; 374: 565-76.

Puvimanasinghe JPA, Takkenberg JJM, Edwards MB, et al.Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation. Heart. 2004; 90: 1172–78.

Lund O, Bland M. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg. 2006; 132: 20–26.

Kouchoukos Nicholas T, Blackstone Eugene H, Doty Donald B, et al. Kirklin/Barrat-Boyes Cardiac Surgery. 3rd edition. Churchill Livingstone 2003: 527-532.

Butany J, Ahluwalia MS, Munroe C, et al. Mechanical heart valve prostheses: identification and evaluation. Cardiovasc Pathol. 2003; 12: 322–44.

Starr A, Edwards M. Mitral replacement: clinical experience with a ball valve prosthesis. Ann Surg. 1961; 154: 726–40.

Bjork VO. A new tilting disc valve prosthesis. Scan J Thorac Cardiovasc Surg. 1969; 3: 1–10.

Butany J, Fayet C, Ahluwalia MS, et al. Biological replacement heart valves. Identifi cation and evaluation. Cardiovasc Pathol. 2003; 12: 119–39.

Berkowitz SD. Antithrombotic therapy after prosthetic cardiac valve implantation: potential novel antithrombotic therapies. Am Heart J. 2001; 142: 7–13.

Bonow RO, Carabello BA, Chaterjee K, et al. ACC/AHA 2006 practice guidelines for the management of patients with valvular heart disease: executive summary: a report of the American Col-lege of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2006; 48: 598–675.

Salem DN, O’Gara PT, Madias C, Pauker SG; American Col-lege of Chest Physicians. Valvular and structural heart disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed). Chest. 2008; 133: 593S–629S.

Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994; 89: 635–41.

Heras M, Chesebro JH, Fuster V, et al. High risk of thromboem-bolism early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol.1995; 25: 1111–9.

Asopa S, Patel A, Dunning J. Is short-term anticoagulation necessary after mitral valve repair? Interact Cardiovasc Thorac Surg.2006; 5: 761– 66.

Dunning J, Versteegh M, Fabbri A, et al. Guideline on anti-platelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg. 2008; 34: 73–92.

Brunton Laurence L, Lazo John S, Parker Keith L. Goodman & Gillman’s The Pharmacological Basis of Therapeutics 11thed. Chapter 54. McGraw-Hill 2006.
Views & Downloads
Abstract views: 1011   
PDF (Bahasa Indonesia) downloads: 1656   
How to Cite
Syahputra, A., & Yuniadi, Y. (1). Anti-coagulant therapy after valvular heart surgery. Indonesian Journal of Cardiology, 31(2), 118-125.
Review Article